Mangoceuticals, Inc. (MGRX) shareholders
Close on Nov 16, 2026Market cap $3.46MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Jacob D. Cohen Joint filing with The Tiger Cub Trust (15.50%) | 4,098,333 | 21.50% | 13D (active) amendment | Mar 9, 2026 |
| Greenfield Investments, Ltd Joint filing with Peter M. Karam (14.44%) | 515,000 | 14.44% | 13G (passive) | Dec 13, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MGRX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 338,964 | 1.57% | $128.81K | New | 0.00% |
| XTX Topco Ltd | 186,256 | 0.86% | $70.78K | +173,114 | 0.00% |
| Geode Capital Management, LLC | 156,243 | 0.72% | $59.37K | −38,239 | 0.00% |
| Ikarian Capital, LLC | 138,146 | 0.64% | $52.50K | – | 0.01% |
| Vanguard Capital Management LLC | 123,041 | 0.57% | $46.76K | – | 0.00% |
| Vanguard Fiduciary Trust Co | 57,163 | 0.27% | $21.72K | – | 0.00% |
| Boothbay Fund Management, LLC | 38,441 | 0.18% | $14.61K | – | 0.00% |
| Northern Trust Corp | 37,579 | 0.17% | $14.28K | – | 0.00% |
| Hrt Financial LP | 36,003 | 0.17% | $13.00K | New | 0.00% |
| Ackerman Capital Advisors, LLC | 34,500 | 0.16% | $13.11K | – | 0.00% |
| ACT Advisors, LLC. | 26,863 | 0.12% | $10.21K | New | 0.00% |
| Goldman Sachs Group Inc | 11,589 | 0.05% | $4.40K | −168 | 0.00% |
| Csenge Advisory Group | 10,000 | 0.05% | $3.80K | – | 0.00% |
| Ameriflex Group, Inc. | 2,885 | 0.01% | $1.10K | New | 0.00% |
| Fortitude Family Office, LLC | 1,343 | 0.01% | $510 | – | 0.00% |
| Morgan Stanley | 1,000 | 0.00% | $380 | – | 0.00% |
| Tower Research Capital LLC (TRC) | 783 | 0.00% | $298 | −2 | 0.00% |
| Barclays PLC | 5 | 0.00% | $2 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 18 | 1M | 5.6% | 5 / 1 | 3 / 4 | 1M | 0M |
| Q1 2026 | 18 | 1M | 3.8% | 5 / 5 | 1 / 4 | 0M | 2M |
| Q4 2025 | 18 | 3M | 11.8% | 10 / 5 | 1 / 3 | 2M | 0M |
| Q3 2025 | 11 | 0M | 1.7% | 4 / 3 | 1 / 3 | 0M | 0M |
| Q2 2025 | 10 | 0M | 1.4% | 3 / 3 | 1 / 1 | 0M | 0M |
| Q1 2025 | 8 | 0M | 0.3% | 1 / 4 | 1 / 2 | 0M | 0M |
| Q4 2024 | 9 | 0M | 0.4% | 9 / 0 | 0 / 1 | 0M | 0M |
| Q3 2024 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
5 funds held MGRX in Q2 2026, 47% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of MGRX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 123,041 | 0.57% | $46.76K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 109,105 | 0.51% | $46.92K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 14,438 | 0.07% | $6.21K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 12,606 | 0.06% | $5.42K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 453 | 0.00% | $195 | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jacob D. Cohen | Chief Executive Officer, Director, 10% owner | 11,305,000 | 52.42% | Oct 6, 2026 |
| Antonios Isaac | President, Director | 60,000 | 0.28% | Apr 11, 2025 |
| Eugene M. Johnston | CFO | 220,000 | 1.02% | Oct 6, 2026 |
| Alex P. Hamilton | Director | 101,667 | 0.47% | Oct 6, 2026 |
| Kenny Myers | Director | 136,667 | 0.63% | Sep 12, 2025 |
| Lorraine Pamela D'Alessio | Director | 136,667 | 0.63% | Sep 12, 2025 |
| Cub Trust Tiger | 10% owner | 605,000 | 2.81% | Oct 6, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jacob D. Cohen Chief Executive Officer, Director, 10% owner | Aug 11, 2026 | Gift | +2,000,000 | – | – | 3,305,000 |
| Jacob D. Cohen Chief Executive Officer, Director, 10% owner | Aug 11, 2026 | Gift | −2,000,000 | – | – | 0 |
| Jacob D. Cohen Chief Executive Officer, Director, 10% owner | Jul 28, 2026 | Award | +2,000,000 | – | – | 2,000,000 |
| Eugene M. Johnston CFO | Jul 28, 2026 | Award | +100,000 | – | – | 220,000 |
| Alex P. Hamilton Director | Jul 28, 2026 | Award | +100,000 | – | – | 101,667 |
| Eugene M. Johnston CFO | Dec 15, 2025 | Sale | −3,333 | $1.17 | $3.90K | 120,000 |
| Eugene M. Johnston CFO | Dec 9, 2025 | Sale | −5,000 | $1.20 | $6.00K | 123,333 |
| Eugene M. Johnston CFO | Dec 5, 2025 | Sale | −10,000 | $1.13 | $11.30K | 128,333 |
| Alex P. Hamilton Director | Nov 19, 2025 | Sale | −125,000 | $1.22 | $152.50K | 3,334 |
| Jacob D. Cohen Chief Executive Officer, Director, 10% owner | Sep 30, 2025 | Gift | +500,000 | – | – | 1,305,000 |
| Jacob D. Cohen Chief Executive Officer, Director, 10% owner | Sep 30, 2025 | Gift | −500,000 | – | – | 0 |
| Jacob D. Cohen Chief Executive Officer, Director, 10% owner | Sep 9, 2025 | Award | +500,000 | – | – | 500,000 |
| Eugene M. Johnston Chief Financial Officer | Sep 9, 2025 | Award | +100,000 | – | – | 138,334 |
| Alex P. Hamilton Director | Sep 9, 2025 | Award | +100,000 | – | – | 126,667 |
| Kenny Myers Director | Sep 9, 2025 | Award | +100,000 | – | – | 136,667 |
| Lorraine Pamela D'Alessio Director | Sep 9, 2025 | Award | +100,000 | – | – | 136,667 |
| Jacob D. Cohen Chief Executive Officer, Director, 10% owner | Jun 5, 2025 | Gift | +200,000 | – | – | 805,000 |
| Jacob D. Cohen Chief Executive Officer, Director, 10% owner | Jun 5, 2025 | Gift | −200,000 | – | – | 0 |
| Cub Trust Tiger 10% owner | Apr 10, 2025 | Award | +200,000 | – | – | 200,000 |
| Lorraine Pamela D'Alessio Director | Apr 10, 2025 | Award | +25,000 | – | – | 36,667 |
| Kenny Myers Director | Apr 10, 2025 | Award | +25,000 | – | – | 36,667 |
| Cub Trust Tiger 10% owner | Apr 10, 2025 | Award | +200,000 | – | – | 200,000 |
| Antonios Isaac President, Director | Apr 10, 2025 | Award | +60,000 | – | – | 60,000 |
| Alex P. Hamilton Director | Apr 10, 2025 | Award | +25,000 | – | – | 28,334 |
| Eugene M. Johnston Chief Financial Officer | Nov 11, 2024 | Award | +25,000 | – | – | 38,334 |
| Jacob D. Cohen Chief Executive Officer, Director, 10% owner | Aug 26, 2024 | Gift | +800,000 | – | – | 9,075,000 |
| Jacob D. Cohen Chief Executive Officer, Director, 10% owner | Aug 26, 2024 | Gift | −800,000 | – | – | 0 |
| Alex P. Hamilton Director | Jun 26, 2024 | Sale | −108,426 | $0.32 | $34.70K | 50,000 |
| Alex P. Hamilton Director | Jun 25, 2024 | Sale | −16,574 | $0.31 | $5.14K | 158,426 |
| Lorraine Pamela D'Alessio Director | Jun 3, 2024 | Award | +100,000 | – | – | 175,000 |
| Cub Trust Tiger 10% owner | Jun 3, 2024 | Award | +800,000 | – | – | 800,000 |
| Amanda Elizabeth Hammer Chief Operating Officer | Jun 3, 2024 | Award | +100,000 | – | – | 175,000 |
| Alex P. Hamilton Director | Jun 3, 2024 | Award | +100,000 | – | – | 175,000 |
| Kenny Myers Director | Jun 3, 2024 | Award | +100,000 | – | – | 175,000 |
| Eugene M. Johnston Chief Financial Officer | Oct 3, 2023 | Award | +50,000 | – | – | 200,000 |
| Amanda Elizabeth Hammer Chief Operating Officer | May 1, 2023 | Award | +75,000 | – | – | 75,000 |
| Cub Trust Tiger 10% owner | Apr 10, 2023 | Buy | +275,000 | $1.00 | $275.00K | 8,275,000 |
| Cub Trust Tiger 10% owner | Apr 4, 2023 | Gift | −8,000,000 | – | – | 0 |
| Cub Trust Tiger 10% owner | Apr 4, 2023 | Gift | +8,000,000 | – | – | 8,000,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Mangoceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 149,792 shares on Aug 21, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Eugene M. Johnston Officer | Dec 3, 2025 | 128,333 | $148.87K | Dec 3, 2025 | Stock Grants |
| Alex P. Hamilton Director | Nov 19, 2025 | 125,000 | $155.13K | Nov 19, 2025 | Stock Award |
| Alex P. Hamilton Board of Director | Jun 24, 2024 | 150,000 | $52.50K | Jun 21, 2024 | Pre-IPO |
| Alex P. Hamilton Board Member | Jun 20, 2024 | 150,000 | $52.50K | Jun 21, 2024 | Pre-IPO |
| Alex P. Hamilton Board of Directors | Jun 18, 2024 | 50,000 | $15.00K | Jun 21, 2024 | pre-IPO shares |
| Alex P. Hamilton Self | Jun 10, 2024 | 50,000 | $21.50K | Jun 10, 2024 | PRE IPO SHARES |
See a number that looks wrong?